Keyword: Acorda Therapeutics

News

Biotech Firm Buys Maker of Late-Stage Parkinson’s Drug

25.09.2014 - US-based Acorda Therapeutics has acquired privately held Civitas Therapeutics for $525 million to gain access to a Parkinson's disease drug in late-stage development. With the buy...

News

Pharma Asks The Money Question Earlier For New Drugs

22.12.2011 - GlaxoSmithKline executive German Pasteris is in charge of an Alzheimer's treatment that is years from reaching the market, if it ever does. But he already wants to make sure the...